Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Enteral nutrition, also known as tube feeding, refers to any method of feeding that uses the gastrointestinal (GI) tract to deliver caloric requirements, including normal oral diet or liquid supplements. Nasoenteral, also known as nasogastric feeding tube, is placed in the stomach through the nose, whereas a jejunostomy tube is placed directly through the skin. The tube feeding formula is used in patients suffering from chronic conditions including head trauma, cancer, and stroke. Moreover, the nutrition formula helps premature infants to gain required nutrition and medications.

The global enteral nutrition market is estimated to be valued at US$ 2,635.9 million in 2020 and is expected to exhibit a CAGR of 5.8% over the forecast period (2020-2027).

Figure 1. Global Enteral Nutrition Market Share (%) in Terms of Value, By Region, 2020

Enteral Nutrition  | Coherent Market Insights

Rising prevalence of chronic diseases is expected to drive the market growth over the forecast period

Enteral nutrition is recommended for patients with chronic disease conditions in order to combat the weak immune system which affect eating habits resulting in drastic weight loss. Moreover, the increasing prevalence of chronic diseases such as diabetes, chronic kidney disease, and malnutrition is expected to drive the global enteral nutrition market growth over the forecast period.

According to the International Diabetes Federation (IDF), in 2019, 463 million adults across the globe in the age group of 20 to 79 had diabetes and this is expected to reach 700 million by 2045, resulting in 51.2% increase between 2019 and 2045. As per the International Diabetes Federation (IDF), around 374 million people worldwide currently are at a higher risk of developing type 2 diabetes.

According to the Cancer Research UK report published in 2018, around 17 million new cancer cases were diagnosed in 2018 and around 9.6 million deaths occurred due to cancer in 2018.

Moreover, the rising prevalence of malnutrition is driving growth of the global enteral nutrition market. According to Feeding America 2015, around 2 million people suffer from starvation in the U.S, including 13 million children.

request-sample

Enteral Nutrition Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2020: US$ 2,635.9 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 5.8% 2027 Value Projection: US$ 3,903.7 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, Colombia, Peru, and Rest of Latin America
  • Asia Pacific: Japan, China, South Korea, Vietnam, Philippines, India, Thailand, Indonesia, Malaysia, Australia, Taiwan, and Rest of Asia Pacific
  • Europe, Middle East and Africa: Germany, France, Italy, U.K., Netherlands, Spain, Saudi Arabia, Russia, Egypt, South Africa, Turkey, Sweden, and Rest of Europe, Middle East and Africa
Segments covered:
  • By Product Type: Standard Enteral Nutrition, Enteral Nutrition for Chronic Illness.
  • By Nutrition Type: Proteins, Carbohydrates, Multi-vitamins and Antioxidants, Amino Acid, Fibers, Minerals, Others.
  • By Formulation: Powder, Liquid.
  • By Patient Type: Infant (1 month to 2 years), Children (2 to 12 years), Adolescent & Adult (12 to 65 years), Geriatric (>65 years), Chronic Patient (Excluding all above in all age groups)
  • By Application: Cancer, Gastrointestinal Diseases, Diabetes, Critical Care, Others.
  • By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, E-commerce.
  • By End User: Hospitals, Home Care Settings, Retirement Homes, Others.
Companies covered:

Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP

Growth Drivers:
  • Rising prevalence of chronic diseases
  • Increasing government initiatives, investments, and funding for research and development
Restraints & Challenges:
  • Side effects and complications caused by enteral feedings
  • Lack of awareness regarding healthcare, diet, and proper nutrition in low and middle income economies

Figure 2. Global Enteral Nutrition Market Share (%), by Product Type, 2020

Enteral Nutrition  | Coherent Market Insights

Increasing government initiatives, investments, and funding for research and development is expected to drive the market growth over the forecast period

For instance, in September 2017, the government of Tanzania launched the National Multi-sectoral Nutrition Action Plan (NMNAP) for 2016-2021 to address problems with malnutrition in the Tanzania. The Nutrition International’s Technical Assistance Program partnered with the government of Tanzania on this project.

Moreover, factors such as investments in research and development of novel medical nutritional products targeting various health conditions, as well as funding by various companies operating in nutrition industries are expected to drive the global enteral nutrition market growth over the forecast period.

For instance, in May 2020, Danone’s nutrition health arm, Nutricia, granted US$ 1.1 million for global nutrition research programme, a clinician-initiated research project in 16 countries across the world, to define guidelines for nutritional care for COVID-19 patients recovering after intensive care unit (ICU) admission.

Global Enteral Nutrition Market – Impact of Coronavirus (Covid-19) Pandemic

Following the outbreak of COVID-19 in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it a public health emergency. According to the World Health Organization’s report, the manifestation of the coronavirus (COVID-19) has resulted in more than 106 million infected individuals worldwide as of 9th February 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to nationwide lockdowns, several countries such as China, India, Saudi Arabia, UAE, Egypt, and others are facing problems with regards to transportation of drugs from one place to another.

Moreover, demand for enteral nutritional products has increased significantly during the pandemic, as nutrition therapy is recommended to patients affected with COVID-19 infection. It is more important to evaluate the nutrition status of the COVID-19 infected patients. According to data published by the American Society of Parenteral and Enteral Nutrition (ASPEN), all guidelines and recommendations available for clinical nutrition in critically ill patients also apply for severely ill COVID-19 patients.

Global Enteral Nutrition Market Restraint

The major factors restraining growth of the enteral nutrition market are the side effects and complications caused by enteral feedings. If a child has gastroesophageal reflux, aggressive enteral feeding may increase the risk of aspiration or vomiting. Other physical disadvantages are diarrhea, skin breakdown, or anatomic disruption. Mechanical disadvantages include a dislodged or occluded feeding tube.

Furthermore, lack of awareness regarding healthcare, diet, and proper nutrition in low and middle income economies is a major factor hampering growth of the global enteral nutrition market.

Key Players

Major players operating in the global enteral nutrition market include Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.

Enteral nutrition refers to delivery of food containing carbohydrates, proteins, water, fat, minerals, and vitamins in the body using gastrointestinal tract with the help of feeding tubes. It is imperative for patients having functional gastrointestinal tract however are, unable to maintain a safe or adequate oral intake. Furthermore, a tube placed in nose, is known as nasoenteral tube, where it passes through the nasal cavity and into the stomach. However, when a tube passes through the skin into the stomach, it is called gastrostomy. Such tubes aid patients to ingest food, who are unable to consume normally.

Market Dynamics

Increasing incidence of chronic diseases such as cancer, diabetes, gastrointestinal disorder, and cardiovascular diseases, increasing novel product launch and approvals, and increasing adoption of growth strategies such as acquisition and collaboration by key players operating in the market are the important factors expected to drive the market growth over the forecast period. For instance, in September 2019, Nestlé Health Science in collaboration with StartSe and R&D manufacturing specialists launched ‘Nestle Beyond Food’, a nutrition-based health program. Through this program, Nestle selected Brazilian startup businesses it wished to work with based on their business execution, nutritional support for outpatient, nutritional product solutions, and e-Health technologies.

Moreover, in March 2017, B. Braun Medical Ltd., launched a new range of nutritionally complete dietary drinks - Nutricomp Drink Plus. It is available in four flavors; the high-energy milkshake style supplement can be prescribed for the dietary management of malnutrition and can also be administered by tube in critically weak patients.

Key features of the study:

  • This report provides in-depth analysis of the global enteral nutrition market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2020–2027), considering 2019 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global enteral nutrition market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global enteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global enteral nutrition market

Detailed Segmentation:

  • Global Enteral Nutrition Market, By Product Type:
    • Standard Enteral Nutrition
    • Enteral Nutrition for Chronic Illness
  • Global Enteral Nutrition Market, By Nutrition Type:
    • Proteins
    • Carbohydrates
    • Multi-vitamins and Antioxidants
    • Amino Acid
    • Fibers
    • Minerals
    • Others
  • Global Enteral Nutrition Market, By Formulation:
    • Powder
    • Liquid
  • Global Enteral Nutrition Market, By Patient Type:
    • Infant (1 month to 2 years)
    • Children (2 to 12 years)
    • Adolescent & Adult (12 to 65 years)
    • Geriatric (>65 years)
    • Chronic Patient (Excluding all above in all age groups)
  • Global Enteral Nutrition Market, By Application:
    • Cancer
    • Gastrointestinal Diseases
    • Diabetes
    • Critical Care
    • Others
  • Global Enteral Nutrition Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • E-commerce
  • Global Enteral Nutrition Market, By End User:
    • Hospitals
    • Home Care Settings
    • Retirement Homes
    • Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
  • Global Enteral Nutrition Market, By Region:
    • North America
      • By Product Type
        • Standard Enteral Nutrition
        • Enteral Nutrition for Chronic Illness
      • By Nutrition Type
        • Proteins
        • Carbohydrates
        • Multi-vitamins and Antioxidants
        • Amino Acid
        • Fibers
        • Minerals
        • Others
      • By Formulation
        • Powder
        • Liquid
      • By Patient Type
        • Infant (1 month to 2 years)
        • Children (2 to 12 years)
        • Adolescent & Adult (12 to 65 years)
        • Geriatric (>65 years)
        • Chronic Patient (Excluding all above in all age groups)
      • By Application
        • Cancer
        • Gastrointestinal Diseases
        • Diabetes
        • Critical Care
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • E-commerce
      • By End User
        • Hospitals
        • Home Care Settings
        • Retirement Homes
        • Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Product Type
        • Standard Enteral Nutrition
        • Enteral Nutrition for Chronic Illness
      • By Nutrition Type
        • Proteins
        • Carbohydrates
        • Multi-vitamins and Antioxidants
        • Amino Acid
        • Fibers
        • Minerals
        • Others
      • By Formulation
        • Powder
        • Liquid
      • By Patient Type
        • Infant (1 month to 2 years)
        • Children (2 to 12 years)
        • Adolescent & Adult (12 to 65 years)
        • Geriatric (>65 years)
        • Chronic Patient (Excluding all above in all age groups)
      • By Application
        • Cancer
        • Gastrointestinal Diseases
        • Diabetes
        • Critical Care
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • E-commerce
      • By End User
        • Hospitals
        • Home Care Settings
        • Retirement Homes
        • Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
      • By Country
        • Brazil
        • Argentina
        • Mexico 
        • Colombia
        • Peru
        • Rest of Latin America
    • Asia Pacific
      • By Product Type
        • Standard Enteral Nutrition
        • Enteral Nutrition for Chronic Illness
      • By Nutrition Type
        • Proteins
        • Carbohydrates
        • Multi-vitamins and Antioxidants
        • Amino Acid
        • Fibers
        • Minerals
        • Others
      • By Formulation
        • Powder
        • Liquid
      • By Patient Type
        • Infant (1 month to 2 years)
        • Children (2 to 12 years)
        • Adolescent & Adult (12 to 65 years)
        • Geriatric (>65 years)
        • Chronic Patient (Excluding all above in all age groups)
      • By Application
        • Cancer
        • Gastrointestinal Diseases
        • Diabetes
        • Critical Care
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • E-commerce
      • By End User
        • Hospitals
        • Home Care Settings
        • Retirement Homes
        • Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
      • By Country
        • Japan
        • China
        • South Korea
        • Vietnam
        • Philippines
        • India
        • Thailand
        • Indonesia
        • Malaysia
        • Australia
        • Taiwan
        • Rest of Asia Pacific
    • Europe, Middle East, and Africa
      • By Product Type
        • Standard Enteral Nutrition
        • Enteral Nutrition for Chronic Illness
      • By Nutrition Type
        • Proteins
        • Carbohydrates
        • Multi-vitamins and Antioxidants
        • Amino Acid
        • Fibers
        • Minerals
        • Others
      • By Formulation
        • Powder
        • Liquid
      • By Patient Type
        • Infant (1 month to 2 years)
        • Children (2 to 12 years)
        • Adolescent & Adult (12 to 65 years)
        • Geriatric (>65 years)
        • Chronic Patient (Excluding all above in all age groups)
      • By Application
        • Cancer
        • Gastrointestinal Diseases
        • Diabetes
        • Critical Care
        • Others
      • By Distribution Channel
        • Hospital Pharmacies
        • Retail Pharmacies
        • E-commerce
      • By End User
        • Hospitals
        • Home Care Settings
        • Retirement Homes
        • Others (Nursing Care Centers, Rehabilitation Care Centers, etc.)
      • By Country
        • Germany
        • France
        • Italy
        • U.K.
        • Netherlands
        • Spain
        • Saudi Arabia
        • Russia
        • Egypt
        • South Africa
        • Turkey
        • Sweden
        • Rest of Europe, Middle East and Africa
  • Company Profiles
    • Abbott Laboratories*
      • Company Overview
      • Material Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Nestlé S.A.
    • Danone S.A.
    • Fresenius Kabi AG
    • Mead Johnson & Company, LLC
    • Braun Melsungen AG
    • Otsuka Pharmaceutical Co., Ltd
    • Meiji Holdings Co., Ltd.
    • Bahrain Pharma
    • Bionova Lifesciences
    • Global Health Products Inc.
    • Victus Inc.
    • Curtis Health Caps SP

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Nutrition Type
      • Market Snippet, By Formulation
      • Market Snippet, By Patient Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Regulatory Scenario, By Country
    • Reimbursement Scenario, By Country
    • Key Developments
    • PEST Analysis
    • List of Contract Manufacturers
    • Mergers, Acquisitions and Collaboration Scenario
    • Product Launch/Approvals
    • Market Trends
    • Major Brand Analysis
    • Epidemiology
    • Value Chain Analysis/Product Journey
  4. Global Enteral Nutrition Market – Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Research and Development
    • Government Measures to combat COVID-19
    • COVID-19 Epidemiology
  5. Global Enteral Nutrition Market, By Product Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Standard Enteral Nutrition
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Enteral Nutrition for Chronic Illness
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Enteral Nutrition Market, By Nutrition Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Proteins
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Carbohydrates
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Multi-vitamins and Antioxidants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Amino Acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Fibers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Minerals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Enteral Nutrition Market, By Formulation, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Powder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Liquid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Enteral Nutrition Market, By Patient Type, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Infant (1 month to 2 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Children (2 to 12 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Adolescent & Adult (12 to 65 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Geriatric (>65 years)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Chronic Patient (Excluding all above in all age groups)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  9. Global Enteral Nutrition Market, By Application, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cancer
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gastrointestinal Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diabetes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Critical Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  10. Global Enteral Nutrition Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • E-commerce
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  11. Global Enteral Nutrition Market, By End User, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Home Care Settings
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retirement Homes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  12. Global Enteral Nutrition Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Argentina
        • Mexico 
        • Colombia
        • Peru
        • Rest of Latin America
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Japan
        • China
        • South Korea
        • Vietnam
        • Philippines
        • India
        • Thailand
        • Indonesia
        • Malaysia
        • Australia
        • Taiwan
        • Rest of Asia Pacific
    • Europe, Middle East, and Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Nutrition Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Formulation, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Patient Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • France
        • Italy
        • U.K. 
        • Netherlands 
        • Spain 
        • Saudi Arabia
        • Russia 
        • Egypt 
        • South Africa 
        • Turkey 
        • Sweden 
        • Rest of Europe, Middle East and Africa
  13. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
      • Abbott Laboratories *
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Nestlé S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Danone S.A.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Fresenius Kabi AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Mead Johnson & Company, LLC
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braun Melsungen AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Otsuka Pharmaceutical Co., Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Meiji Holdings Co., Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bahrain Pharma
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Bionova Lifesciences
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Global Health Products Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Victus Inc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Curtis Health Caps SP
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
    • Analyst Views
  14. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 287 market data tables and 88 figures on "Enteral Nutrition Market” - Global forecast to 2027

Frequently Asked Questions

The global enteral nutrition market size is estimated to be valued at US$ 2,635.9 million in 2020 and is expected to exhibit a CAGR of 5.8% between 2020 and 2027.
Rising prevalence of chronic diseases and increasing government initiatives, investments, and funding for research and development are expected to drive the market growth over the forecast period.
Standard enteral nutrition segment is expected to hold the major market share, owing to increasing product approvals and launches during the forecast period.
North America holds the largest market share in the market.
Major factors hampering growth of the global enteral nutrition market include side effects and complications caused by enteral feedings and lack of awareness regarding healthcare, diet, and proper nutrition in low and middle income economies.
Major players operating in the market include Abbott Laboratories, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, B. Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., and Curtis Health Caps SP.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner